MPRX Recalls Testosterone Topical Cream 4% Due to Expired Components
MPRX, Inc. dba Medical Park Pharmacy is recalling Testosterone Topical Cream 4% because it was compounded using expired components and has incorrect or missing lot and expiration dates.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a situation where use of the product could cause temporary or medically reversible health consequences. The source text describes labeling errors and the use of expired components but does not report any illnesses or injuries, fitting the criteria for a moderate severity score.
Plain-English summary
MPRX, Inc. dba Medical Park Pharmacy is recalling Testosterone Topical Cream 4% due to labeling issues and the use of expired components. The recall involves 3 bottles of the product with Lot 61463:42 and a use-by date of 02/27/2020.
The FDA has classified this as a Class II recall. The specific defects identified are incorrect or missing lot and/or expiration dates, and the fact that the products were compounded using expired components.
The affected products were distributed in Texas (TX). Consumers who have this specific lot of Testosterone Topical Cream 4% should stop using it and contact the recalling firm for instructions on how to return or dispose of the product.
The recalled product
- Product
- Testosterone Topical Cream 4%
- Manufacturer
- MPRX, Inc. dba Medical Park Pharmacy
- Category
- Drug — Topical Steroid
- Affected units
- 3
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 61463:42 Use by: 02/27/2020
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 18 recalled by MPRX, Inc. dba Medical Park Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 18 products in this recall →Related recalls
Same manufacturer · MPRX, Inc. dba Medical Park Pharmacy
See all →- ModerateProgesterone 50 mg Capsules Recalled for Expired Components
FDA (Drugs) · 2020-02-05
- ModerateMedical Park Pharmacy Recalls Naltrexone Capsules Due to Labeling Errors
FDA (Drugs) · 2020-02-05
- ModerateMedical Park Pharmacy Recalls Lidocaine/Prilocaine Cream Due to Expired Components
FDA (Drugs) · 2020-02-05
- ModerateMedical Park Pharmacy Recalls Finasteride/Biotin Due to Expired Components
FDA (Drugs) · 2020-02-05
- ModerateMedical Park Pharmacy Recalls Liothyronine Due to Expired Components
FDA (Drugs) · 2020-02-05
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateKRS Global Biotechnology Recalls Progesterone 3% Topical Cream Due to Labeling Errors
FDA (Drugs) · 2018-01-17
- LowLupin Recalls Testosterone Topical Solution Due to Pump Defects
FDA (Drugs) · 2019-03-27
- SevereTestosterone Pellets Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereTestosterone Sterile Pellets Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23
- SevereFDA Recalls Testosterone Pellets Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereFDA Recalls Testosterone and Anastrazole Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-09-23